Crossref
journal-article
Elsevier BV
Current Opinion in Chemical Biology (78)
References
39
Referenced
138
10.1038/35057062
/ Nature / Initial sequencing and analysis of the human genome by Lander (2001)10.1126/science.1058040
/ Science / The sequence of the human genome by Venter (2001){'key': '10.1016/S1367-5931(00)00229-5_BIB3', 'series-title': 'Human Disease — from Genetic Causes to Biochemical Effects', 'first-page': '5', 'author': 'Drews', 'year': '1997'}
/ Human Disease — from Genetic Causes to Biochemical Effects by Drews (1997)10.1038/nbt1297-1318
/ Nat Biotechnol / The role of innovation in drug development by Drews (1997)- Incyte and Vertex Enter Genomic Partnership to Accelerate Drug Discovery in Multi-target Gene Families Using LifeSeq Gold on World Wide Web URL: http://www.vpharm.com/Pressreleases2000/pr022900.html
10.1016/S0968-0896(98)00126-6
/ Bioorg Med Chem / Chemical genetics resulting from a passion for synthetic organic chemistry by Schreiber (1998)10.1146/annurev.pharmtox.40.1.177
/ Annu Rev Pharmacol Toxicol / Drug discovery in the next millennium by Ohlstein (2000){'issue': 'Supp 7', 'key': '10.1016/S1367-5931(00)00229-5_BIB8', 'first-page': '5', 'article-title': 'Systematization of Research', 'volume': '384', 'author': 'Lehman', 'year': '1996', 'journal-title': 'Nature'}
/ Nature / Systematization of Research by Lehman (1996)10.1016/S1074-5521(99)80013-1
/ Chem Biol / Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era by Frye (1999)10.2174/1386207003331472
/ Comb Chem High Throughput Screen / Forecasting roles of combinatorial chemistry in the age of genomically derived drug discovery targets by Thorpe (2000)10.1146/annurev.pharmtox.40.1.193
/ Annu Rev Pharmacol Toxicol / The impact of genomics on drug discovery by Debouck (2000)10.1016/S1074-5521(97)90194-0
/ Chem Biol / The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase by Wilson (1997)10.1021/bi981591x
/ Biochemistry / Molecular basis for p38 protein kinase inhibitor specificity by Lisnock (1998)10.1002/pro.5560071102
/ Protein Sci / A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase by Fox (1998)10.1074/jbc.273.25.15605
/ J Biol Chem / Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket by Gum (1998)10.1002/prot.1057
/ Proteins / Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes by Mahalingam (2001)10.1110/ps.9.10.1898
/ Protein Sci / Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance by Hong (2000)10.1126/science.280.5360.69
/ Science / The structure of the potassium channel: molecular basis of K+ conduction and selectivity by Doyle (1998)10.1126/science.289.5480.739
/ Science / Crystal structure of rhodopsin: a G protein-coupled receptor by Palczewski (2000)10.1038/35055559
/ Nature / The gating mechanism of the large mechanosensitive channel MscL by Sukharev (2001)10.1002/(SICI)1098-1128(200001)20:1<28::AID-MED2>3.0.CO;2-2
/ Med Res Rev / ATP site-directed competitive and irreversible inhibitors of protein kinases by Garcia-Echeverria (2000)10.1016/S1367-5931(99)80067-2
/ Curr Opin Chem Biol / The development and therapeutic potential of protein kinase inhibitors by Cohen (1999)10.1006/jmbi.1998.2369
/ J Mol Biol / Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine by Lamers (1999)10.1016/S0955-0674(96)80067-6
/ Curr Opin Cell Biol / Regulation of transcription by MAP kinase cascades by Treisman (1996)10.1111/j.1749-6632.1998.tb08307.x
/ Ann New York Acad Sci / Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme by Dinarello (1998)10.1016/S0197-0186(99)00061-3
/ Neurochem Int / Recent advances on neuronal caspases in development and neurodegeneration by Marks (1999)10.1016/S1074-5521(00)00123-X
/ Chem Biol / The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity by Wei (2000)10.1016/S0169-409X(96)00423-1
/ Adv Drug Deliv Rev / Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings by Lipinski (1997)10.1016/S1359-6446(97)01163-X
/ Drug Discov Today / Virtual screening: an overview by Walters (1998){'year': '2000', 'series-title': 'Library Filtering Systems and Prediction of Drug-Like Properties', 'key': '10.1016/S1367-5931(00)00229-5_BIB30'}
/ Library Filtering Systems and Prediction of Drug-Like Properties (2000)10.1021/jm970666c
/ J Med Chem / Can we learn to distinguish between ‘drug-like’ and ‘nondrug-like’ molecules? by Ajay (1998)10.1021/jm990017w
/ J Med Chem / Designing libraries with CNS activity by Ajay (1999)10.1021/jm9602928
/ J Med Chem / The properties of known drugs. 1. Molecular frameworks by Bemis (1996)10.1021/jm9903996
/ J Med Chem / Properties of known drugs. 2. Side chains by Bemis (1999)10.1016/S0065-7743(08)60591-6
/ Ann Rep Med Chem / Structure-based drug design by Murcko (1999)10.1021/jm990352k
/ J Med Chem / Consensus scoring: a method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins by Charifson (1999)10.1016/S1074-5521(00)80022-8
/ Chem Biol / The SHAPES strategy: an NMR-based approach for lead generation in drug discovery by Fejzo (1999)10.1016/S0076-6879(02)38221-1
/ Methods Enzymol / NMR-based approaches for lead generation in drug discovery by Peng (2001)10.1126/science.287.5460.1960
/ Science / Drug discovery: a historical perspective by Drews (2000)
Dates
Type | When |
---|---|
Created | 22 years, 10 months ago (Oct. 11, 2002, 4:03 a.m.) |
Deposited | 6 years, 4 months ago (April 25, 2019, 12:23 a.m.) |
Indexed | 2 months, 2 weeks ago (June 6, 2025, 5:08 a.m.) |
Issued | 24 years ago (Aug. 1, 2001) |
Published | 24 years ago (Aug. 1, 2001) |
Published Print | 24 years ago (Aug. 1, 2001) |
@article{Caron_2001, title={Chemogenomic approaches to drug discovery}, volume={5}, ISSN={1367-5931}, url={http://dx.doi.org/10.1016/s1367-5931(00)00229-5}, DOI={10.1016/s1367-5931(00)00229-5}, number={4}, journal={Current Opinion in Chemical Biology}, publisher={Elsevier BV}, author={Caron, Paul R and Mullican, Michael D and Mashal, Robert D and Wilson, Keith P and Su, Michael S and Murcko, Mark A}, year={2001}, month=aug, pages={464–470} }